Publications by authors named "Hilde Langseth"

Claim this Profile
E
Esophageal and Gastric Cancer Incidence and Mortality Trends in Norway, 1993-2022: A Registry-Based Study.
Monireh Sadat Seyyedsalehi, Paolo Boffetta, Cassia B Trewin-Nybråten, Hilde Langseth, Trude Eid Robsahm

Clin Epidemiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for Validating Omics Prediction Models: Insights from a Lung Cancer RNA Biomarker Study.
Luca Pestarino, Renée Turzanski Fortner, Therese H Nøst, Ioannis Fotopoulos, Ilona Urbarova, Hilde Langseth

Cancer Epidemiol Biomarkers Prev· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-RNA sequencing identifies serum microRNAs associated with abnormal electrocardiography findings in patients with Chagas disease.
Michael Mueller, Alice Blandino, Dominique Scherer, Inés Zulantay, Werner Apt, Hilde Langseth

J Infect· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Storage Time up to Nine Years at -25°C on 15 Selected Biochemical Serum Components.
Steffan Daniel Bos, Marianne Lauritzen, Randi E Gislefoss, Nathalie Støer, Olav I Klingenberg, Hilde Langseth

Biopreserv Biobank· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer.
Victoria Cooley, Renée Turzanski Fortner, Trasias Mukama, Sabine Naudin, Valeria Pala, Hilde Langseth

Int J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-steroidal anti-inflammatory medication use and endometrial cancer survival: A population-based Norwegian cohort study.
Ala Jabri Haug, Nathalie Støer, Hilde Langseth, Franziska Siafarikas, Edoardo Botteri

Int J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediagnostic Serum Immune Marker Levels and Multiple Myeloma: A Prospective Longitudinal Study Using Samples from the Janus Serum Bank in Norway.
Simona Herdenberg, Carl Wibom, Esmeralda J M Krop, Hilde Langseth, Roel Vermeulen

Cancer Prev Res (Phila)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Study Consortium for the Discovery and Validation of Early Detection Markers for Ovarian Cancer - Baseline Findings for CA125.
Rudolf Kaaks, Victoria Cooley, Trasias Mukama, Lauren R Teras, Alpa V Patel, Hilde Langseth

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian cancer survival by residual disease following cytoreductive surgery: a nationwide study in Norway.
Cassia B Trewin-Nybråten, Sigrid Leithe, Torbjørn Paulsen, Hilde Langseth, Renée Turzanski Fortner

Br J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data Resource Profile: EULAT Eradicate GBC: the European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer.
Dominique Scherer, Carol Barahona Ponce, Claudio Mengoa, Paola Montenegro, Hector Losada, Hilde Langseth

Int J Epidemiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs and epithelial ovarian cancer survival: a registry-based cohort study in Norway.
Nathalie C Støer, Edoardo Botteri, Kristina Lindemann, Hilde Langseth, Renée Turzanski Fortner

BMC Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: Results from a three-stage collaborative study of large European prospective cohorts.
Alice Blandino, Dominique Scherer, Felix Boekstegers, Trine B Rounge, Hilde Langseth

Eur J Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of self-reported number of pregnancies and maternal age at first birth among females attending organized mammographic screening.
Kaitlyn M Tsuruda, Hilde Langseth, Giske Ursin, Solveig Hofvind, R T Fortner

Scand J Public Health· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential levels of circulating RNAs prior to endometrial cancer diagnosis.
Sina Rostami, Trine B Rounge, Luca Pestarino, Robert Lyle, Renée Turzanski Fortner, Hilde Langseth

Int J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of miRNA signatures for ovarian cancer earlier detection in the pre-diagnosis setting using machine learning approaches.
Konrad Stawiski, Renée T Fortner, Luca Pestarino, Sinan U Umu, Rudolf Kaaks, Hilde Langseth

Front Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediagnostic Hormone Levels and Risk of Testicular Germ Cell Tumors: A Nested Case-Control Study in the Janus Serum Bank.
Zeni Wu, Britton Trabert, Chantal Guillemette, Patrick Caron, Gary Bradwin, Hilde Langseth

Cancer Epidemiol Biomarkers Prev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway.
Renée Turzanski Fortner, Cassia B Trewin-Nybråten, Torbjørn Paulsen, Hilde Langseth

Int J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic and static circulating cancer microRNA biomarkers - a validation study.
Masood Abu-Halima, Andreas Keller, Lea Simone Becker, Ulrike Fischer, Annika Engel, Hilde Langseth

RNA Biol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
Hilary A Robbins, Aida Ferreiro-Iglesias, Tim Waterboer, Nicole Brenner, Mari Nygard, Hilde Langseth

J Clin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia.
Eleanor L Watts, Aurora Perez-Cornago, Georgina K Fensom, Karl Smith-Byrne, Urwah Noor, Hilde Langseth

Int J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Insights in life-course epidemiology and social inequalities: 2021.
Cyrille Delpierre, Hilde Langseth

Front Public Health· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3).
Mary K Townsend, Britton Trabert, Renée T Fortner, Alan A Arslan, Julie E Buring, Hilde Langseth

Int J Epidemiol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis.
Julia Simon, Nicole Brenner, Sibylle Reich, Hilde Langseth, Bo T Hansen

Cancer Epidemiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum RNAs can predict lung cancer up to 10 years prior to diagnosis.
Sinan U Umu, Hilde Langseth, Verena Zuber, Åslaug Helland, Robert Lyle

Elife· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter].
Bettina K Andreassen, Helga H Hektoen, Karol Axcrona, Hilde Langseth, Jo S Stenehjem

Clin Epidemiol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis